Dipyridamole
-
Subject Areas on Research
- Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
- Arteritis with impaired renal function.
- Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty.
- Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty.
- Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
- Dipyridamole myocardial SPECT with low heart rate response indicates cardiac autonomic dysfunction in patients with diabetes.
- Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers.
- Echocardiography for the assessment of myocardial viability.
- Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation.
- Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
- Effect of dipyridamole plus aspirin on hemodialysis graft patency.
- Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening.
- Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables.
- Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
- MRI quantitative myocardial perfusion with compartmental analysis: a rest and stress study.
- Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
- Phase II trial of 5-fluorouracil, high-dose leucovorin calcium, and dipyridamole in advanced prostate cancer.
- Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol.
- Protection of perfused lung from oxidant injury by inhibitors of anion exchange.
- Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease.
- Stimulation of long-chain fatty acid uptake by dipyridamole in isolated myocytes.
- Stress echocardiography, contrast echocardiography, and tissue characterization: applications for the future.
- Tc-99m sestamibi cardiac SPECT imaging during coronary artery occlusion in humans: comparison with dipyridamole stress studies.
- Thallium-201 myocardial imaging in patients with coronary artery disease: comparison of intravenous adenosine and oral dipyridamole.
- The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer.
- Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
- Use of aspirin associates with longer primary patency of hemodialysis grafts.
- Use of common antiplatelet drugs for vascular diseases.
- [Computed tomography with thallium-201 and oral dipyridamole in the diagnosis of coronary artery disease].